New 'Smart Bomb' drug trial targets Hard-to-Treat cancers
NCT ID NCT04300556
Summary
This study is testing a new drug called MORAb-202 in people with advanced ovarian, endometrial, lung, or triple-negative breast cancer. The main goals are to find a safe dose and see if the drug can shrink tumors. The drug is designed to target cancer cells specifically, and some participants may also receive it with another cancer drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ACRC/Arizona Clinical Research Center, Inc
WITHDRAWNTucson, Arizona, 85715, United States
-
Ascension Illinois-Skokie Infustion Center
WITHDRAWNSkokie, Illinois, 60077, United States
-
Beatson West of Scotland Cancer Centre-PPDS
COMPLETEDGlasgow, Glasgow City, G12 0YN, United Kingdom
-
Belfast City Hospital
WITHDRAWNBelfast, Antrim, BT9 7AB, United Kingdom
-
CLCC-Gustave Roussy Cancer
COMPLETEDVilejuif, Val-de-Marne, 94805, France
-
Cancer Institute Hospital of JFCR
RECRUITINGKoto-ku, Tokyo, 1358550, Japan
-
Centre Antoine Lacassagne Centre R gional de Lutte Contre Le Cancer
COMPLETEDNice, Alpes-Maritimes, 06100, France
-
Centre Fran ois Baclesse
COMPLETEDCaen, Calvados, 1400, France
-
Centre Hospitalier de La C te Basque
COMPLETEDBayonne, Pyrenees-Atlantiques, 64109, France
-
Centre L on B rard Centre R gional de Lutte Contre Le Cancer Rh ne Alpes
COMPLETEDLyone, Rhone, 69008, France
-
Centre Oscar Lambret
COMPLETEDLille, Nord, 59000, France
-
Chattanooga's Program in Women's Oncology
COMPLETEDChattanooga, Tennessee, 37403, United States
-
Clinica Universidad de Navarra
COMPLETEDMadrid, 28027, Spain
-
Clinique Armoricaine de Radiologie-PPDS
WITHDRAWNSaint-Brieuc, Cote-d'Amore, 22000, France
-
Clinique Catherine de Sienne
WITHDRAWNNantes, Loir-Atlantique, 44200, France
-
Columbia University Medical Center
COMPLETEDNew York, New York, 10032, United States
-
EDOG Institut de Cancerologie de l Ouest
COMPLETEDNantes, Loir-Atlantique, 44000, France
-
Fundacion Instituto Valenciano de Oncologia
COMPLETEDValencia, 46009, Spain
-
Georgia Cancer Center
RECRUITINGAugusta, Georgia, 30912, United States
-
Guy's and St Thomas's Hospital
COMPLETEDLondon, London, City of, SE1 9RT, United Kingdom
-
H pital de la Croix Saint-Simon
COMPLETEDParis, 75020, France
-
Henry Ford Hospital
WITHDRAWNDetroit, Michigan, 48202, United States
-
Hopital Cochin
COMPLETEDParis, 75679, France
-
Hopitaux de La Timone
COMPLETEDMarseille, Bouches-du-Rhone, 13385, France
-
Hospital Clinico San Carlos
COMPLETEDMadrid, 28040, Spain
-
Hospital Clinico Universitario de Valencia
RECRUITINGValencia, 46010, Spain
-
Hospital General Universitario Gregorio Mara on
COMPLETEDMadrid, 28007, Spain
-
Hospital Universitari i Politecnic La Fe de Valencia
COMPLETEDValencia, 46013, Spain
-
Hospital Universitario Ramon y Cajal
COMPLETEDMadrid, 28304, Spain
-
Hospital Universitario Vall d'Hebron
RECRUITINGBarcelona, 08035, Spain
-
Hospital Universitario de Toledo
COMPLETEDToledo, 45007, Spain
-
ICANS - Institut de canc rologie Strasbourg Europe
COMPLETEDStrasbourg, Bas-Rhin, 67200, France
-
ICO Badalona-H.U. Germans Trias i Pujol
RECRUITINGBadalona, Barcelona, 08916, Spain
-
Institut Paoli Calmettes
COMPLETEDMarseille, Bouches-du-Rhone, 13009, France
-
Karmanos Cancer Institute
COMPLETEDDetroit, Michigan, 48201, United States
-
Lancashire Clinical Research Facility, Royal Preston Hospital
COMPLETEDPreston, Lancanshire, PR2 9HT, United Kingdom
-
MD Anderson Cancer Center at Cooper
COMPLETEDCamden, New Jersey, 08103, United States
-
Medical University of South Carolina
WITHDRAWNCharleston, South Carolina, 29425, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Moffitt Cancer Center and Research Institute
RECRUITINGTampa, Florida, 33612, United States
-
Mount Vernon Cancer Centre
COMPLETEDNorthwood, Middlesex, HA6 2RN, United Kingdom
-
National Cancer Center Hospital
RECRUITINGChuo-ku, Tokyo, 1040045, Japan
-
Northwestern Memorial Hospital
RECRUITINGChicago, Illinois, 60611, United States
-
Norton Healthcare
WITHDRAWNLouisville, Kentucky, 40202, United States
-
OSU Wxner Medical Center
WITHDRAWNHilliard, Ohio, 43026, United States
-
Oregon Health & Science University
WITHDRAWNPortland, Oregon, 97239, United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
COMPLETEDBaltimore, Maryland, 21287, United States
-
Stanford Women's Cancer Center
RECRUITINGPalo Alto, California, 94304, United States
-
The Christie NHS Foundation Trust
COMPLETEDManchester, Lancanshire, M20 4BX, United Kingdom
-
The Royal Marsden in Sutton
WITHDRAWNSutton, Surrey, SM2 5PT, United Kingdom
-
The University of Texas MD Anderson Cancer Center
WITHDRAWNHouston, Texas, 77030, United States
-
University of Cincinnati Medical Center
COMPLETEDCincinnati, Ohio, 45219, United States
-
University of Miami
COMPLETEDCoral Gables, Florida, 33146, United States
-
University of Virginia Comprehensive Cancer Center
COMPLETEDCharlottesville, Virginia, 22903, United States
-
Universty of Arkansas for Medical Sciences
COMPLETEDLittle Rock, Arkansas, 72205, United States
-
Vanderbilt University Medical Center
WITHDRAWNNashville, Tennessee, 07677, United States
-
Velindre Cancer Centre-PPDS
COMPLETEDCardiff, South Glamorgan, CF14 2TL, United Kingdom
-
Winship Cancer Institute
COMPLETEDAtlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.